Testicular cancer is often a younger man’s disease. While it can occur at any age, it most often affects men in their 20s and 30s. Coping with cancer is tough at any age. But young men with testicular cancer may worry not just about their prognosis but a...
Read MoreWhat To Know About Pancreatic Cancer Risk Factors
About 1 in 64. That’s how many people will get pancreatic cancer during their lifetime. No one knows exactly why some people develop this cancer—or how to avoid it. At Fox Chase Cancer Center, a research team led by surgical oncologist Sanjay S. Reddy, M...
Read MoreWhat To Know About Pancreatic Cancer Risk Factors
Facing Breast Cancer Under 40
Breast cancer is most common in older women. But it's also one of the most common cancers in women under 40. And younger women with breast cancer face unique challenges. Younger adults with cancer often feel like their life plan is being irrevocably alte...
Read MoreFacing Breast Cancer Under 40
An Intimate Look at Sex After Cancer
Originally published in Forward, Spring/Summer 2017 By Paige Allen Cancer can take people through a series of waiting rooms, infusion rooms, operating rooms, and hospital rooms. When it’s over, another problem can be lurking in a different room: t...
Read MoreAn Intimate Look at Sex After Cancer
A New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read MoreA New Phase 1 Clinical Trial for Non-Small Cell Lung Cancer
A New Stage 2-4 Clinical Trial for HIV-associated Hodgkin Lymphoma
As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...
Read MoreA New Stage 2-4 Clinical Trial for HIV-associated Hodgkin Lymphoma
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this